Dr Emily Mathiak, OD | |
10110 South 7650 East, Crow Agency, MT 59022 | |
(406) 638-3465 | |
Not Available |
Full Name | Dr Emily Mathiak |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 12 Years |
Location | 10110 South 7650 East, Crow Agency, Montana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790047819 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 4901004704 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
P H S Indian Hospital Crow / Northern Cheyenne | Crow agency, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Us Health Dept Of Health And Human Services | 9638081623 | 77 |
News Archive
Human T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus similar to human immunodeficiency virus (HIV) and has mostly been thought to be transmitted vertically (mother-to-child), or horizontally (sexually or parenterally (e.g. via blood transfusion)).
Kaiser Health News provides a fresh take on health policy developments with "And Call Me In The Morning" By Nick Anderson.
Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract the disease, which has been on the upswing in childhood and adolescence.
Results of an analysis from the University of Cincinnati College of Medicine show that additional therapy, or adjuvant therapy, delivered after surgical removal of a rare type of gastrointestinal tumor does not increase survival rates for patients.
› Verified 9 days ago
Provider Name | Us Health Dept Of Health & Human Services |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1972694602 PECOS PAC ID: 9638081623 Enrollment ID: O20031106000399 |
News Archive
Human T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus similar to human immunodeficiency virus (HIV) and has mostly been thought to be transmitted vertically (mother-to-child), or horizontally (sexually or parenterally (e.g. via blood transfusion)).
Kaiser Health News provides a fresh take on health policy developments with "And Call Me In The Morning" By Nick Anderson.
Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract the disease, which has been on the upswing in childhood and adolescence.
Results of an analysis from the University of Cincinnati College of Medicine show that additional therapy, or adjuvant therapy, delivered after surgical removal of a rare type of gastrointestinal tumor does not increase survival rates for patients.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Emily Mathiak, OD Po Box 9, Crow Agency, MT 59022-0009 Ph: (406) 638-3465 | Dr Emily Mathiak, OD 10110 South 7650 East, Crow Agency, MT 59022 Ph: (406) 638-3465 |
News Archive
Human T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus similar to human immunodeficiency virus (HIV) and has mostly been thought to be transmitted vertically (mother-to-child), or horizontally (sexually or parenterally (e.g. via blood transfusion)).
Kaiser Health News provides a fresh take on health policy developments with "And Call Me In The Morning" By Nick Anderson.
Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract the disease, which has been on the upswing in childhood and adolescence.
Results of an analysis from the University of Cincinnati College of Medicine show that additional therapy, or adjuvant therapy, delivered after surgical removal of a rare type of gastrointestinal tumor does not increase survival rates for patients.
› Verified 9 days ago
Barbara Suzanne Cohn, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 Hospital Road, Crow Indian Health Service- Optometry, Crow Agency, MT 59022 Phone: 406-638-3313 Fax: 406-638-3341 |